News

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...
Cambridge: Moderna has received approval from the U.S. Food and Drug Administration (FDA) for the supplemental Biologics ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
RNA Victoria funds 2 Florey projects to prevent and treat Alzheimer's diseaseKey points mRNA Victoria has funded 2 Alzheimer's disease research ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
A Pennsylvania Representative is looking to ban testing mRNA vaccines on domestic animals. Representative Jacob Banta (R-Erie ...
The mRNA therapeutics field is rapidly evolving beyond vaccines to include treatments for cancer, genetic disorders and in vivo cell therapies, bringing with it diverse production challenges. As the ...
DelveInsight's, “Melanoma Pipeline Insight” report provides comprehensive insights about 150+ companies and 170+ pipeline ...
The mRNA molecule is too large to pass through a cell membrane by free diffusion and carries multiple negative charges, increasing the difficulty of their delivery.
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.